terazosin

Generic: terazosin

Labeler: ajanta pharma usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin
Generic Name terazosin
Labeler ajanta pharma usa inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 2 mg/1

Manufacturer
Ajanta Pharma USA Inc.

Identifiers & Regulatory

Product NDC 27241-289
Product ID 27241-289_ec1b00c3-3d59-420a-a71c-e9bd9a8d02fd
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA219482
Listing Expiration 2027-12-31
Marketing Start 2025-05-12

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 27241289
Hyphenated Format 27241-289

Supplemental Identifiers

RxCUI
260376 313215 313217 313219
UPC
0327241289019 0327241291012 0327241290015 0327241288012
UNII
D32S14F082

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin (source: ndc)
Generic Name terazosin (source: ndc)
Application Number ANDA219482 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (27241-289-01)
  • 1000 CAPSULE in 1 BOTTLE (27241-289-10)
source: ndc

Packages (2)

27241-289-01 100 CAPSULE in 1 BOTTLE (27241-289-01) 27241-289-10 1000 CAPSULE in 1 BOTTLE (27241-289-10)

Ingredients (1)

terazosin hydrochloride (2 mg/1)

Linked Drug Pages (1)

Terazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "ec1b00c3-3d59-420a-a71c-e9bd9a8d02fd", "openfda": {"upc": ["0327241289019", "0327241291012", "0327241290015", "0327241288012"], "unii": ["D32S14F082"], "rxcui": ["260376", "313215", "313217", "313219"], "spl_set_id": ["bed99c2a-4266-4a2c-bb0f-7643fdafff78"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (27241-289-01)", "package_ndc": "27241-289-01", "marketing_start_date": "20250512"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (27241-289-10)", "package_ndc": "27241-289-10", "marketing_start_date": "20250512"}], "brand_name": "Terazosin", "product_id": "27241-289_ec1b00c3-3d59-420a-a71c-e9bd9a8d02fd", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "27241-289", "generic_name": "Terazosin", "labeler_name": "Ajanta Pharma USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA219482", "marketing_category": "ANDA", "marketing_start_date": "20250512", "listing_expiration_date": "20271231"}